These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 26417849

  • 21. Transcending antibiotic resistance: The potential of mass Galla chinensis et camelliae Fermentata to Dismantle Helicobacter pylori biofilms and enhance anti-biotic activity.
    Zhang Y, Hou Y, Ye H, Wang X, Zhang X, Yu J.
    J Ethnopharmacol; 2024 Nov 15; 334():118594. PubMed ID: 39032662
    [Abstract] [Full Text] [Related]

  • 22. Antimicrobial and Antibiofilm Activities of Carvacrol, Amoxicillin and Salicylhydroxamic Acid Alone and in Combination vs. Helicobacter pylori: Towards a New Multi-Targeted Therapy.
    Puca V, Turacchio G, Marinacci B, Supuran CT, Capasso C, Di Giovanni P, D'Agostino I, Carradori S, Grande R.
    Int J Mol Sci; 2023 Feb 24; 24(5):. PubMed ID: 36901886
    [Abstract] [Full Text] [Related]

  • 23. Anti-Helicobacter pylori effect of mucoadhesive nanoparticles bearing amoxicillin in experimental gerbils model.
    Umamaheshwari RB, Ramteke S, Jain NK.
    AAPS PharmSciTech; 2004 Apr 07; 5(2):e32. PubMed ID: 15760090
    [Abstract] [Full Text] [Related]

  • 24. In vitro effect of clarithromycin and alginate lyase against helicobacter pylori biofilm.
    Bugli F, Palmieri V, Torelli R, Papi M, De Spirito M, Cacaci M, Galgano S, Masucci L, Paroni Sterbini F, Vella A, Graffeo R, Posteraro B, Sanguinetti M.
    Biotechnol Prog; 2016 Nov 07; 32(6):1584-1591. PubMed ID: 27535356
    [Abstract] [Full Text] [Related]

  • 25. Formulation and evaluation of stomach-specific amoxicillin-loaded carbopol-934P mucoadhesive microspheres for anti-Helicobacter pylori therapy.
    Patel JK, Chavda JR.
    J Microencapsul; 2009 Jun 07; 26(4):365-76. PubMed ID: 18720199
    [Abstract] [Full Text] [Related]

  • 26. Nanoparticles incorporated in pH-sensitive hydrogels as amoxicillin delivery for eradication of Helicobacter pylori.
    Chang CH, Lin YH, Yeh CL, Chen YC, Chiou SF, Hsu YM, Chen YS, Wang CC.
    Biomacromolecules; 2010 Jan 11; 11(1):133-42. PubMed ID: 19924885
    [Abstract] [Full Text] [Related]

  • 27. Antibiotic polymeric nanoparticles for biofilm-associated infection therapy.
    Cheow WS, Hadinoto K.
    Methods Mol Biol; 2014 Jan 11; 1147():227-38. PubMed ID: 24664837
    [Abstract] [Full Text] [Related]

  • 28. Role of the preliminary susceptibility testing for initial and after failed therapy of Helicobacter pylori infection with levofloxacin, amoxicillin, and esomeprazole.
    Marzio L, Coraggio D, Capodicasa S, Grossi L, Cappello G.
    Helicobacter; 2006 Aug 11; 11(4):237-42. PubMed ID: 16882326
    [Abstract] [Full Text] [Related]

  • 29. Helicobacter pylori free-living and biofilm modes of growth: behavior in response to different culture media.
    Bessa LJ, Grande R, Di Iorio D, Di Giulio M, Di Campli E, Cellini L.
    APMIS; 2013 Jun 11; 121(6):549-60. PubMed ID: 23237527
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Antibiotic susceptibility patterns of Helicobacter pylori strains isolated from northeastern Mexico.
    Garza-González E, Pérez-Pérez GI, Alanís-Aguilar O, Tijerina-Menchaca R, Maldonado-Garza HJ, Bosques-Padilla FJ.
    J Chemother; 2002 Aug 11; 14(4):342-5. PubMed ID: 12420850
    [Abstract] [Full Text] [Related]

  • 33. Engineering bioinspired bacteria-adhesive clay nanoparticles with a membrane-disruptive property for the treatment of Helicobacter pylori infection.
    Ping Y, Hu X, Yao Q, Hu Q, Amini S, Miserez A, Tang G.
    Nanoscale; 2016 Sep 28; 8(36):16486-98. PubMed ID: 27605059
    [Abstract] [Full Text] [Related]

  • 34. Bifunctional Enzyme SpoT Is Involved in Biofilm Formation of Helicobacter pylori with Multidrug Resistance by Upregulating Efflux Pump Hp1174 (gluP).
    Ge X, Cai Y, Chen Z, Gao S, Geng X, Li Y, Li Y, Jia J, Sun Y.
    Antimicrob Agents Chemother; 2018 Nov 28; 62(11):. PubMed ID: 30181372
    [Abstract] [Full Text] [Related]

  • 35. Advanced interpenetrating polymer networks for innovative gastroretentive formulations targeting Helicobacter pylori gastric colonization.
    Grosso R, Benito E, Carbajo-Gordillo AI, Díaz MJ, García-Martín MG, de-Paz MV.
    Eur J Pharm Sci; 2024 Sep 01; 200():106840. PubMed ID: 38909691
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Evaluation of antimicrobial resistance of Helicobacter pylori in the last 15 years in West Poland.
    Karpiński TM, Andrzejewska E, Eder P, Linke K, Szkaradkiewicz A.
    Acta Microbiol Immunol Hung; 2015 Sep 01; 62(3):287-93. PubMed ID: 26551571
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Lipid and polymer nanoparticles for drug delivery to bacterial biofilms.
    Forier K, Raemdonck K, De Smedt SC, Demeester J, Coenye T, Braeckmans K.
    J Control Release; 2014 Sep 28; 190():607-23. PubMed ID: 24794896
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.